UnitedHealth Group (NYSE: UNH) announced its financial results for the first quarter ended March 31, 2026, reporting revenues and earnings that surpassed consensus estimates. The healthcare conglomerate reported total quarterly revenue of $108.4 billion, representing a 9% increase compared to the $99.5 billion reported in the first quarter of 2025. Adjusted earnings per share for the period reached $7.42, exceeding the average analyst projection of $7.15. Following these results, the company officially raised its full-year profit outlook.
The company’s performance was driven by double-digit growth across its Optum health services business and steady expansion within its UnitedHealthcare insurance division. Optum reported revenue of $62.8 billion, up from $56.3 billion a year earlier. Within this segment, Optum Health saw significant growth as it expanded its value-based care models to serve an additional 1.2 million patients compared to the previous year. Optum Insight’s revenue also increased, supported by the integration of advanced data analytics and administrative tools for healthcare providers. Optum Rx, the pharmacy services arm, processed 415 million scripts in the quarter, a 5% increase year-over-year.
UnitedHealthcare, the company’s insurance arm, recorded first-quarter revenue of $78.2 billion. The division added approximately 1.5 million new members over the past twelve months, with gains in the Medicare Advantage and commercial employer markets. The medical care ratio, a key metric representing the percentage of premiums spent on medical claims, was reported at 82.1%. This figure reflects effective management of care costs and a stabilization of utilization trends. Operating costs for the quarter were 13.1% of revenue, down from 13.5% in the prior year, which the company attributed to increased automation in claims processing.
Chief Executive Officer Andrew Witty stated during the earnings call that the company’s diversified portfolio allowed it to navigate evolving regulatory environments while maintaining operational efficiency. Witty highlighted the continued shift toward capitated payment models and the expansion of home-based clinical services as primary contributors to the quarter's results. Chief Financial Officer John Rex noted that the company’s capital allocation strategy included $4.5 billion in share repurchases and $2.1 billion in dividends paid during the quarter.
Based on the first-quarter performance, UnitedHealth Group raised its full-year 2026 outlook for adjusted net earnings. The company now expects adjusted earnings in the range of $28.50 to $29.00 per share, up from the previously issued guidance of $27.75 to $28.25 per share. Management attributed the revised outlook to sustained momentum in Optum’s service delivery and improved operating margins within the UnitedHealthcare Medicare segment. The company also reaffirmed its commitment to investing in digital health infrastructure, allocating an additional $1.5 billion toward technology enhancements for the remainder of the fiscal year.